[1] |
PAN Hongxin, CUI Wangfei, LYU Licheng, WANG Xinzheng, CAO Ling, ZHANG Yongzhen.
Analysis of the incidence and mortality of malignant tumors in tumor registration areas of Shanxi Province,2020
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(6): 700-706.
|
[2] |
LIANG Xiumei, CHEN Weiyi, MA Liang, CHEN Lijun, GONG Wenfeng, YU Hongping, LIU Yingchun.
An analysis of hospitalized death cases of malignant tumors in a tertiary hospital in Guangxi from 2010 to 2020
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(6): 662-666.
|
[3] |
XU Xiaojun, LIAO Dawen, WANG Xingchen, WEI Yuanyuan, HUANG Qichao, DU Yulu.
Research status of mitochondrial retrograde signaling in tumor progression
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(6): 672-676.
|
[4] |
FAN Wan, WANG Jian, BAI Jinshan, ZHANG Jinfeng, LI Linlin, ZHAO Shaohui, YANG Jun, YANG Chun.
Research progress of dietary alkylresorcinols in cancer prevention
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(3): 349-353.
|
[5] |
WANG Fuyuan, WANG Zhaoxia, ZHAO Le, XIN Liqing, HE Simin, WANG Tong.
A prospective cohort study on the effect of circadian clock rhythm related factors on female HPV negative conversion
[J]. Chinese Journal of Oncology Prevention and Treatment, 2022, 14(5): 552-557.
|
[6] |
CAO Ji, GE Lianying, YU Jiahua, RONG Minhua, LI Qiulin.
Development and prospect of Guangxi cancer prevention and control work
[J]. Chinese Journal of Oncology Prevention and Treatment, 2019, 11(4): 271-275.
|